Non-Federal Members Named to the National Alzheimer's Project Advisory Council
August 23, 2011
Health and Human Services Secretary Kathleen Sebelius has added 12 non-federal members to serve on the Advisory Council on Alzheimer's Research, Care, and Services. They are Alzheimer's disease patient advocates, caregivers, health care providers and others with Alzheimer's disease-related expertise who will advise the Secretary on federal programs that impact people with Alzheimer's disease and related dementias.
The full Advisory Council, established May 23, also includes federal members and will meet quarterly to assist in the development of a national plan by HHS, Veterans Affairs, the Department of Defense, and the National Science Foundation to address the disease. The Advisory Council is required by the National Alzheimer's Project Act and its members will serve for overlapping four-year terms.
The National Alzheimer's Project Act, signed by President Obama in January, will help people and families across the country whose lives are touched by Alzheimer's disease. The Act aims to strengthen Alzheimer's research and to improve health and long-term care services for—and reduce the financial burden on—affected individuals.
For more information on the Advisory Committee, please visit http://aspe.hhs.gov/daltcp/napa/
Adapted from U.S. Department of Health & Human Services
View all news updates for Alzheimer's disease
Disclaimer: The information provided in this section is a public service of the BrightFocus Foundation, and should not in any way substitute for the advice of a qualified healthcare professional, and is not intended to constitute medical advice. Although we take efforts to keep the medical information on our website updated, we cannot guarantee that the information on our website reflects the most up-to-date research. Please consult your physician for personalized medical advice; all medications and supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical product or therapy.
Some of the content in this section is adapted from other sources, which are clearly identified within each individual item of information.